Key result
Mechanical valves improve long-term survival ~12% vs bioprosthetic valves in patients aged 50 to 70.
Why the study?
To investigate the safety and efficacy of bioprosthetic versus mechanical valves on long-term outcomes in 50- to 70-year-old aortic stenosis patients.
Does mechanical valve replacement improve long-term outcomes compared to bioprosthetic valve replacement in 50- to 70-year-old patients with aortic stenosis?
Meta-Analysis (n=15,320)
Does mechanical valve replacement improve long-term outcomes compared to bioprosthetic valve replacement in 50- to 70-year-old patients with aortic stenosis?
In patients aged 50 to 70 years with aortic stenosis, mechanical valve replacement is associated with better long-term survival and lower reoperation rates compared to bioprosthetic valves, despite a higher risk of bleeding.
Answers are grounded in this paper and cite their sources.
Survival benefit with mechanical valves should not yet change selection in 50-70yo AS; confirms meta-analyses but requires RCTs.
This study aimed to investigate the safety and efficacy of bioprosthetic (BV) versus mechanical valves (MV) on long-term outcomes in 50- to 70-year-old aortic stenosis (AS) patients. A literature search for articles published until April 2023 yielded 13 eligible studies, with 15,320 patients divided into BV (n = 7,320) and MV (n = 8,000) cohorts. The review was registered prospectively with PROSPERO (CRD42021278777). MV demonstrated a favorable hazard ratio (HR: 1.12, 95% CI: 1.00-1.25, I2 = 60%) and higher survival rates at 5 (OR:1.13, 95% CI: 1.02-1.25, I2 = 42%) and 10 years (OR: 1.13, 95% CI: 1.05-1.23, I2 = 0%). At 15 years, stroke incidence was comparable (OR: 1.12, 95% CI: 0.98-1.27, I2 = 4%). BV showed lower bleeding events (OR: 1.7, 95% CI: 1.18-2.46, I2 = 88%), but MV replacement showed lower reoperation incidence (OR: 0.27, 95% CI: 0.18-0.42, I2 = 85%). MV appears favorable for the long-term approach in AS management compared to BV.
No takes yet. Share an insight, caveat, or question.
Vankayalapati et al. (2024) conducted a meta-analysis in Aortic stenosis (n=15,320). Mechanical valve vs. Bioprosthetic valve was evaluated on Overall long-term survival (HR 1.12, 95% CI 1.00-1.25). Mechanical valve replacement demonstrated a favorable overall survival hazard ratio of 1.12 and higher survival rates at 5 and 10 years compared to bioprosthetic valves in patients aged 50 to 70.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: